Forus vs Infinitus Systems (2026)

AI Health Index verifiedAugust 4, 2026
Verdict

Two attacks on the same obstacle, getting a prescribed medication actually into a patient's hands, from different ends of the process. Forus sits at the point of prescribing and automates the paperwork path: generating and submitting the prior authorization, drafting appeals, routing to pharmacy, verifying benefits and finding affordability programmes, and it is free to the provider. Infinitus automates the phone call that the paperwork path cannot avoid, dialling the payer, holding, and extracting benefits and authorisation status from a representative, then writing the result back as structured data. They are complementary more than competitive. The question worth asking Forus first is who pays for it, because a free platform that routes prescriptions has an economic relationship somewhere, and the answer changes how you read its coverage claims.

The case for Forus
  • The price to the provider is published and it is zero, stated without a trial qualifier, which is a commercial fact worth establishing before comparing anything else.
  • The system acts rather than recommends: it completes and submits authorisation forms and drafts appeals, embedded at the point of prescribing, with coverage stated as any drug, any insurance, any pharmacy.
  • It states plainly that all protected health information is covered under a business associate agreement, alongside SOC 2 Type 2 with the meaningful type named.
The case for Infinitus Systems
  • It automates the payer phone call, which is the part of medication access that no form submission reaches: benefit verification and authorisation status obtained by an agent that dials, waits and speaks to a representative.
  • Call outcomes are written back as structured data rather than left in a transcript, and the architecture is described concretely as a knowledge graph of payer specific rules.
  • Coverage spans both workflow types and customer classes rather than the medication path alone, so the same agent handles benefit verification across therapeutic areas.

This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Forus and Infinitus Systems are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded

At a Glance

Plain facts

Fact Forus Infinitus Systems
Primary category RCM & Prior Auth AI RCM & Prior Auth AI
Founded 2022 2019
Headquarters New York, New York, United States San Francisco, California, United States
Website forus.com infinitus.ai
Attribute Matrix

Side by Side

Axis
F
Forus
I
Infinitus Systems
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Model Supply Chain Disclosure
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
AI Liability and Recourse
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Citable Summaries

Each record in one paragraph

Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.

Forus

The AI Health Index awards Forus its top capability grade on AI Centrality and HIPAA and BAA Posture. Set against Infinitus Systems, Forus grades higher on HIPAA and BAA Posture and Commercial Transparency. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.

Source: AI Health Index, August 2026

Infinitus Systems

The AI Health Index awards Infinitus Systems its top capability grade on several axes, including AI Centrality, Autonomy and Oversight Model and EHR and Interoperability Depth. Set against Forus, Infinitus Systems grades higher on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.

Source: AI Health Index, August 2026

FAQ

Questions buyers ask

Should we choose Forus or Infinitus Systems?

On the axes where the AI Health Index separates them, Forus grades higher on HIPAA and BAA Posture and Commercial Transparency, and Infinitus Systems grades higher on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Model Supply Chain Disclosure. Infinitus Systems leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.

Where do Forus and Infinitus Systems differ most?

The widest separation the AI Health Index records between Forus and Infinitus Systems is on HIPAA and BAA Posture, where Forus grades A and Infinitus Systems grades B. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.

Where do Forus and Infinitus Systems grade the same?

The AI Health Index grades Forus and Infinitus Systems the same on several axes, including AI Centrality, Clinical and Operational Evidence and AI Safety and PHI Stewardship. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.

Disclosure

A product that is free to the provider is being paid for by someone else, and in medication access that is usually a pharmaceutical manufacturer or a pharmacy channel; establish who pays and what they receive, because a platform routing prescriptions has a commercial interest in where they land. Neither vendor publishes a governance framework, bias evaluation or subgroup performance analysis. Infinitus publishes no hosting, residency or subprocessor detail.

Both automate steps that determine whether a patient gets a medication, and neither publishes what happens when the automation is wrong or how a patient learns that an authorisation was denied by a process nobody in the practice ran.